Loading...
Doxorubicin Resistance in Breast Cancer is Driven by Light at Night Induced Disruption of the Circadian Melatonin Signal
Chemotherapeutic resistance, particularly to doxorubicin (Dox), represents a major impediment to successfully treating breast cancer and is linked to elevated tumor metabolism and tumor over-expression and/or activation of various families of receptor- and non-receptor-associated tyrosine kinases. D...
Na minha lista:
| Udgivet i: | J Pineal Res |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490975/ https://ncbi.nlm.nih.gov/pubmed/25857269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jpi.12239 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|